Tema ETFs’s Kailera Therapeutics KLRA Stock Holding History

Tema ETFs’s Portfolio KLRA Stock Details KLRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$159K	Sell	13,945 -94	-0.7%	-$1.59K	0.01%	554
2026 Q2	$309K	Buy	+14,039	New	+$309K	0.01%	484

Other funds holding KLRA

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Tema ETFs's KLRA Position: Q3 2026 in Review

Tema ETFs reduced its Kailera Therapeutics (KLRA) stake by 0.67% in Q3 2026, selling an estimated $1.59K and leaving 13,945 shares worth $159K. The position accounts for 0.01% of the portfolio, ranked #554.

Tema ETFs first reported a position in KLRA in Q2 2026 and has held it in 2 quarters since. The position peaked at $309K in Q2 2026. 8 funds tracked by Wall St. Rank hold KLRA as of Q3 2026.

Tema ETFs held 13,945 shares of Kailera Therapeutics worth $159K as of Q3 2026.
Tema ETFs sold 94 Kailera Therapeutics shares in Q3 2026, an estimated $1.59K.
Kailera Therapeutics made up 0.01% of Tema ETFs's portfolio in Q3 2026, its #554 holding.
Tema ETFs first reported a position in Kailera Therapeutics in Q2 2026 and has held it in 2 quarters since.
Tema ETFs's Kailera Therapeutics position peaked at $309K in Q2 2026.
8 funds tracked by Wall St. Rank held Kailera Therapeutics as of Q3 2026.

Based on Tema ETFs's 13F filing for Q3 2026, filed 16 Oct 2026.